Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
22%
OVERLAP
BY WEIGHT
26
# OF OVERLAPPING
HOLDINGS
XBI
120
HOLDINGS
22%
ALSO IN CANC
CANC
52
HOLDINGS
50%
ALSO IN XBI
SECTOR DRIFT (XBI minus CANC)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
REVOLUTION MEDICINES, INC. | 2.6% | 7.5% | 2.6% |
|
BRIDGEBIO PHARMA, INC. | 2.1% | 4.4% | 2.1% |
|
EXELIXIS INC | 1.8% | 2.8% | 1.8% |
|
GILEAD SCIENCES INC | 1.6% | 2.0% | 1.6% |
|
ABBVIE INC | 1.6% | 2.4% | 1.6% |
XBI Overweight Relative to CANC
|
EXACT SCIENCES CORP | 2.8% |
|
AVIDITY BIOSCIENCES INC | 2.3% |
|
INSMED INC | 2.1% |
|
NATERA INC | 2.1% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.1% |
|
IONIS PHARMACEUTICALS, INC. | 2.0% |
|
BIOGEN IDEC INC | 1.9% |
|
UNITED THERAPEUTICS CORP | 1.9% |
|
INCYTE CORP | 1.8% |
 |
ROIVANT SCIENCES LTD. | 1.8% |
XBI Underweight Relative to CANC
|
ELI LILLY & CO | -5.8% |
|
REVOLUTION MEDICINES, INC. | -4.9% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | -4.0% |
|
ASTRAZENECA PLC | -4.0% |
 |
GENMAB A/S SPONSORED ADR | -3.8% |
|
NOVARTIS AG | -3.5% |
|
COGENT BIOSCIENCES INC | -2.7% |
|
JOHNSON & JOHNSON | -2.5% |
|
CELCUITY INC. | -2.5% |
|
NUVALENT, INC. CLASS A | -2.4% |